1.
Pediatr Infect Dis J
; 27(2): 175-6, 2008 Feb.
Article
in English
| MEDLINE
| ID: mdl-18174866
ABSTRACT
Prophylaxis with palivizumab has been shown to decrease hospitalizations in at-risk infants. Compliance was higher with a home-based rather than a clinic-based system and was associated with decreased hospitalizations and unscheduled medical visits. Home-based delivery of respiratory syncytial virus prophylaxis may be more efficacious in preventing disease through increased compliance and decreased exposure of the high-risk infant to the clinic environment.